Differential regulation of the two principal Runx2/Cbfa1 N-terminal isoforms in response to bone morphogenetic protein-2 during development of the osteoblast phenotype

Endocrinology

Volumn 142, Issue 9, 2001, Pages 4026-4039

  Banerjee, Chaitali ^a   Javed, Amjad ^a   Choi, Je Yong ^a   Green, Jack ^a   Rosen, Vicki ^b   Van Wijnen, Andre J ^a   Stein, Janet L ^a   Lian, Jane B ^a   Stein, Gary S ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; ISOPROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RUNX2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINE; DNA BINDING; GENE EXPRESSION; GENE REPRESSION; MESENCHYME; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOBLAST; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TRANSCRIPTION REGULATION;

EID: 0034878782     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.9.8367     Document Type: Article

References (65)

1. A new transcription factor family associated with human leukemias
2. Mammalian runt-domain proteins and their roles in hematopoiesis, osteogenesis, and leukemia
3. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts
4. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia
5. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development
6. Maturational disturbance of chondrocytes in Cbfa1-deficient mice
7. Regulation of chondrocyte differentiation by Cbfa1
8. Runt homology domain proteins in osteoblast differentiation: AML-3/CBFA1 is a major component of a bone specific complex
9. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation
10. Does adult fracture repair recapitulate embryonic skeletal formation?
11. Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor
12. Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms
13. Transcriptional autoregulation of the bone related CBFA1/RUNX2 gene
14. Proviral insertions induce the expression of bone-specific isoforms of PEBP2αA (CBFA1): Evidence for a new myc collaborating oncogene
15. Cleidocranial dysplasia: Clinical and molecular genetics
16. A RUNX2/PEBP2α A/CBFA1 mutation displaying impaired transactivation and Smad interaction in cleidocranial dysplasia
17. PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene
18. Cbfa1 isoforms exert functional differences in osteoblast differentiation
19. AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization
20. Expression of the runt domain-encoding PEBP2α genes in T cells during thymic development
21. Expression of the PEBP2αA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells
22. Expression of runtB is modulated during chondrocyte differentiation
23. Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfβ
24. Cbfa1 isoform overexpression upregulates osteocalcin gene expression in non-osteoblastic and pre-osteoblastic cells
25. Groucho/TLE/R-Esp proteins associate with the nuclear matrix and repress RUNX (CBFα/AML/PEBP2α) dependent activation of tissue-specific gene transcription
26. Runt homology domain transcription factors (Runx Cbfa and AML) mediate repression of the bone sialoprotein promoter: Evidence for promoter context-dependent activity of Cbfa proteins
27. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2
28. Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro
29. Differentiation of human marrow stromal precursor cells: Bone morphogenetic protein-2 increases OSF2/CBFA1, enhances osteoblast commitment, and inhibits late adipocyte maturation
30. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor β1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation
31. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix
32. Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes
33. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage
34. Structural analysis and characterization of tissue and hormonal responsive expression of the avian bone sialoprotein (BSP) gene
35. CBFa(AML/PEBP2)-related elements in the TGF-β type I receptor promoter and expression with osteoblast differentiation
36. Basal and vitamin D-responsive activity of the rat osteocalcin promoter in stably transfected osteosarcoma cells: Requirement of upstream sequences for control by the proximal regulatory domain
37. Transforming growth factor-β1 responsiveness of the rat osteocalcin gene is mediated by an activator protein-1 binding site
38. AML-2 is a potential target for transcriptional regulation by the t(8;21) and t(12;21) fusion proteins in acute leukemia
39. Indirect and direct disruption of transcriptional regulation in cancer: E2F and AML-1
40. Runx2 is a common target of transforming growth factor β1 and bone morphogenetic protein 2, and cooperation between runx2 and smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12
41. Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31
42. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBFα transcription factors
43. Expression patterns of bone-related proteins during osteoblastic differentiation in MC3T3-E1 cells
44. Smad1 and smad5 act downstream of intracellular signalings of BMP-2 that inhibits myogenic differentiation and reduces osteoblast differentiation in C2C12 myoblasts
45. A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1
46. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis
47. Cbfa1, an essential transcription factor for bone formation, is expressed in testis from the same promoter used in bone
48. An alternative human SRC promoter and its regulation by hepatic nuclear factor (HNF)-1α
49. Tissue-specific and dexamethasone-inducible expression of alkaline phosphatase from alternative promoters of the rat bone/liver/kidney/placenta gene
50. Xenopus laevis c-myc I and II genes: Molecular structure and developmental expression
51. CBFA1 and topoisomerase I mRNA levels decline during cellular aging of human trabecular osteoblasts
52. MAPK pathways activate and phosphorylate the osteoblast-specific transcription factor, Cbfa1
53. Cbfa1 is required for epithelial-mesenchymal interactions regulating tooth development in mice
54. Runx2: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging
55. Further characterization of cells expressing STRO-1 in cultures of adult human bone marrow stromal cells
56. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells
57. Osteogenic imprinting upstream of marrow stromal cell differentiation
58. Development and characterization of conditionally immortalized osteoblast precursor cell lines from human bone marrow stroma
59. Skeletal malformations caused by overexpression of Cbfa1 or its dominant negative form in chondrocytes
60. Identification of osteocalcin mRNA in nonosteoid tissue of rats and humans by reverse transcription-polymerase chain reaction
61. cDNA cloning of alkaline phosphatase from rat osteosarcoma (ROS 17/2.8) cells
62. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture
63. Expression of Smad1 and Smad2 during embryogenesis suggests a role in organ development
64. Failure of Myf5 to support myogenic differentiation without myogenin, MyoD, and MRF4